Ruff Shamim - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 26, 2023, Ruff Shamim's relationship to REATA PHARMACEUTICALS INC (RETA) is Director, and currently has 0 shares of Class A common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RETA insiders.
Data Source: SEC.
Ruff Shamim - Insider Non-Derivative Transactions of RETA Class A common stock
Ruff Shamim - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Sep 27, 2023 | Disposition -- (Class A common stock) | 7359 | 0 | 0 |
Jul 29, 2023 | Sell -- (Class A common stock) | 8235 | 164.53 | 7359 |
Jul 29, 2023 | M -- (Class A common stock) | 1250 | 92.2 | 8609 |
Jul 29, 2023 | M -- (Class A common stock) | 6666 | 92.2 | 15275 |
Jul 29, 2023 | M -- (Class A common stock) | 319 | 92.2 | 15594 |
Jun 8, 2023 | Acquisition -- (Class A common stock) | 454 | 93.61 | 5677 |
Jun 8, 2023 | Acquisition -- (Class A common stock) | 1682 | 93.61 | 7359 |
Mar 11, 2023 | Sell -- (Class A common stock) | 5740 | 83.73 | 5223 |
Mar 11, 2023 | M -- (Class A common stock) | 199 | 27.32 | 5422 |
Mar 11, 2023 | M -- (Class A common stock) | 1326 | 34.76 | 6748 |
Mar 11, 2023 | M -- (Class A common stock) | 4215 | 34.76 | 10963 |